In addition to playing a primary role in the metabolism of nicotine, in turn influencing many smoking behaviors, including quitting smoking, as well as tobacco-related diseases such as lung cancer risk, the CYP2A6 enzyme also metabolizes several other clinically relevant substrates. Here, CYP2A6 is linked to lung cancer.